Evidence map›Paper›PMID 31040625›Full record

ArticleAnnals of gastroenterology

The impact of colonoscopy indication on polyp detection rate.

Fadi Abu Baker, Amir Mari, Deepash Hosadurg, Muhammed Suki, Baruch Ovadia, Oren Gal, Yael Kopelamn

Abstract read
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fadi Abu BakerDepartment of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel; Affiliated to the Technion Faculty of Medicine, Haifa, Israel (Fadi Abu Baker, Muhammed Suki, Baruch Ovadia, Oren Gal, Yael Kopelamn).
Amir MariDepartment of Gastroenterology, Nazareth EMMS Hospital; Affiliated with the Faculty of Medicine, Bar Illan University (Amir Mari).
Deepash HosadurgUniversity College London Hospital (Deepash Hosadurg).
Muhammed SukiDepartment of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel; Affiliated to the Technion Faculty of Medicine, Haifa, Israel (Fadi Abu Baker, Muhammed Suki, Baruch Ovadia, Oren Gal, Yael Kopelamn).
Baruch OvadiaDepartment of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel; Affiliated to the Technion Faculty of Medicine, Haifa, Israel (Fadi Abu Baker, Muhammed Suki, Baruch Ovadia, Oren Gal, Yael Kopelamn).
Oren GalDepartment of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel; Affiliated to the Technion Faculty of Medicine, Haifa, Israel (Fadi Abu Baker, Muhammed Suki, Baruch Ovadia, Oren Gal, Yael Kopelamn).
Yael KopelamnDepartment of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel; Affiliated to the Technion Faculty of Medicine, Haifa, Israel (Fadi Abu Baker, Muhammed Suki, Baruch Ovadia, Oren Gal, Yael Kopelamn).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdenoma/polyp detection rates are considered to be among the most important quality indicators of colonoscopy and are key measures of a quality procedure. However, they are designed for use in the screening setting and are not amenable to other colonoscopy indications. Little is known about their significance in other colonoscopy indications. We aimed to evaluate the impact of the various indications on polyp detection rate (PDR).

methodsThis was a retrospective, single-center study. Electronic reports of index colonoscopy procedures with adequate bowel preparation over a 10-year period were reviewed. Patients were divided into 7 groups based on the study indication. PDR was determined for each group and was compared to that of a control group, the screening indication group. Adjustment was made for potential confounders such as age, sex, and procedural setting.

resultsA total of 13,054 patients were considered suitable for the study. PDR was greatest in the positive fecal occult blood test group, with a value of 33.1% (P<0.01). Overall, the remaining groups showed similar PDRs compared with screening (22.1% vs. 20.4%; P=0.15). This trend persisted in a multivariate analysis, which showed the odds ratio in the positive fecal occult blood test group to be significantly higher, with a value of 1.955 (1.759-2.172, P<0.001) compared with the screening group.

conclusionPDR was highest for the positive fecal occult blood test indication, but was not affected significantly by most indications. Further randomized studies are warranted to confirm these findings and help calculate recommended thresholds for "overall" PDR.

Indexed as

non-screening colonoscopyPolyp detection ratequality indicator

Identifiers

PMID31040625
PMCPMC6479646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.